Akili Inc reports results for the quarter ended in March - Earnings Summary

Akili

14/05/2024 22:01

* Akili Inc  AKLI.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -17
cents.  The lone analyst forecast for the quarter was for a loss
of 14 cents per share. 
    * Revenue rose 238.9% to $383.00 thousand from a year ago;
analysts expected $794.00 thousand. 
    * Akili Inc's reported EPS for the quarter was a loss of 12
cents​.
    * The company reported a quarterly loss of $9.76 million.
    * Akili Inc shares had risen by 51.4% this quarter and
lost 10.0%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 17.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "hold."

Wall Street's median 12-month price target for Akili Inc is
$0.65 
This summary was machine generated from LSEG data May 14 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.14          -0.12          Beat
 Dec. 31 2023      -0.21                         
 Sep. 30 2023      -0.19          -0.18          Beat
 Jun. 30 2023      -0.20          -0.16          Beat